Bioretec Ltd. BRETEC
OMXHEX · Finland · Health Technology
€0.0270+0.00 (+0.75%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Bioretec Oy Company release 2 June 2026 at 13:25 p.m. EEST
Bioretec Ltd initiates change negotiations in accordance with the Finnish Act on Co-operation within Undertakings. The aim of the negotiations is to streamline operations and consequently to improve the company's competitiveness and profitability. The negotiations will focus on Bioretec's production function in Finland.
Bioretec Ltd Company Announcement -1 June 2026 at 19:05 p.m. EEST
Bioretec Ltd Company release 29 April 2026 at 16:40 p.m. EEST
Bioretec Oy Company release 28 April 2026 at 16:55 p.m. EEST
As previously announced, Bioretec Ltd ("Bioretec" or the "Company") has completed a rights issue (the "Offering"), in which a total of 1,286,801,534 new shares of the Company were subscribed for. The new shares subscribed for in the Offering have been registered with the trade register maintained by the Finnish Patent and Registration Office on 28 April 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.